The ABPI Board has confirmed that Susan Rienow, UK Country President of Pfizer, will be the next President of the Association of the British Pharmaceutical Industry (ABPI).
Rienow was appointed as ABPI Vice-President in September 2022 and will formally take up her role as President in May 2023.
As President, Rienow will lead the ABPI Board to deliver the organisation’s mission to make the UK the best place in the world to research, develop and use new medicines and vaccines.
At Pfizer, Rienow leads the organisation across the breadth of Pfizer’s innovative medicines and vaccines portfolio. She previously led Pfizer UK’s Vaccines business unit during the Covid-19 pandemic.
Commenting on her appointment, Rienow said: “I’m delighted to be taking up the role of ABPI President at such a huge moment of opportunity for both the UK and our industry. Our industry is developing a new generation of medicines and vaccines, and I look forward to working with colleagues across the industry, Government and the NHS to ensure these can help transform the lives of people across the country”.
